PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
|
|
- Jack Chandler
- 5 years ago
- Views:
Transcription
1 CASE #1
2 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
3 OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment options
4 EPIDEMIOLOGY DEPRESSION IS COMMON Healthy, independent community-dwelling older adults have lower prevalence than general adult population Higher prevalence of depression in nursing home and hospital settings The breakdown: 6-10% primary care clinics 12-50% nursing home 30-45% inpatients Most depression treatment for older adults happens in primary care (>80%) Patients may misperceive as normal consequence of aging Depression vs. Grief
5 CONSEQUENCES OF DEPRESSION Depression associated with: Increased use of health care (ED, office visits, drugs, longer length of stay, cost of care) Excess disability Poor health outcomes Higher mortality Increased risk of developing dementia (AD, vascular)
6 SUICIDE RISK Attempt less, but complete more often ~25% of all completions Highest risk: white men age 85 or older For most, was 1 st episode of depression & had seen a doctor in last month Risk factors Hopelessness Insomnia Psychosis ETOH use Poorly controlled pain Worsening comorbid illness Social isolation, widowed Prior attempt Ask about guns
7 HOW DOES DEPRESSION LOOK DIFFERENT IN OLDER PATIENTS? More somatic symptoms; less depressed mood/guilt Patients with advanced physical illness may be pre-occupied with thoughts of death & worthlessness Depression in late life is more likely to become chronic with frequent relapses Extensive comorbidity increases risk of relapse Comorbid anxiety common Watch for comorbid substance use ETOH, pain meds, sleep aidesà falls, cognitive impairment, accidents Men vs. women Men: anger, irritability, apathy, ETOH abuse, less sadness Vascular depression in men
8 OTHER DIAGNOSES TO CONSIDER Persistent depressive disorder (dysthymia) Depressive sx on majority of days for 2 yrs, at risk for MDD Subsyndromal depression/minor depression Depressive sx but don t meet other DX criteria Common in older adults Associated with poorer outcomes, responds to treatment Vascular depression Following CVA or with chronic CNS ischemic changes, Increased risk of vascular dementia Anhedonia, apathy, executive function impairment, slowing, parkinsonism Dementia syndrome of depression Onset of cognitive sx after onset of mood sx Cognitive sx improve with mood improvement Increased risk of developing dementia
9 OTHER DIAGNOSES TO CONSIDER MDD with psychotic features (hallucinations, delusions) Bipolar disorder with mixed features (mania)
10 DEPRESSION SCREENING TOOLS 2-item screen GDS (5-item) PHQ-9 (9-item) Cornell (19-item) Sensitivity (%) Specificity (%) Inpatient Outpatient Physically ill Cognitively impaired Unknown Yes Unknown No Yes Yes Yes Unknown Unknown Yes Yes Unknown Yes Yes Unknown Yes 1) During the past month, have you been bothered by feeling down, depressed or hopeless? 2) During the past month, have you been bothered by little interest or pleasure in doing things?"
11 Covers the 9 DSM-V criteria for MDD Can be used to establish a diagnosis Can be used to monitor treatment response Developed for outpatient setting
12 GERIATRIC DEPRESSION SCALE (GDS) Yes/no format may be easier No somatic or sleep questions No question on suicidal ideation Not useful for assessing treatment response Studied in multiple settings (including inpatient) 5-item version: (2/5=positive screen) Are you basically satisfied with your life? Do you often get bored? Do you often feel helpless? Do you prefer to stay at home rather than going out and doing new things? Do you feel pretty worthless the way you are now?
13 OTHER ASSESSMENTS Functional assessment Social support Cognitive assessment
14 PRINCIPLES OF TREATMENT: MEDS VS. THERAPY Antidepressant medications and structured psychotherapies are equally effective Pharmacotherapy (alone or in combination) is recommended for moderate/severe depression Combination therapy recommended for chronic depression Late-Life Depression NEJM 2007; 357:
15 PSYCHOSOCIAL AND BEHAVIORAL INTERVENTIONS Effective psychotherapy options include: Cognitive behavior therapy (focuses on correcting negative thought associated with depression) Problem-solving therapy (helps patients learn strategies for solving everyday problems associated with depression) Interpersonal psychotherapy (focus on interpersonal causes of depression) CBT best if have comorbid anxiety (GAD) Aerobic exercise (e.g., 12-week, group-based) 45-65% reduction in sx, benefits persist if you keep exercising Bright light (1hr early-morning BLT x 3 wks) Other social interventions (church or community groups)
16 COLLABORATIVE CARE FOR DEPRESSION Emphasize patient/caregiver education Non-MD mental health professionals or depression care managers Integrated psychiatric and primary care Improves outcomes Depressive sx, suicidality, physical function, quality of life, mortality for severe depression Benefits sustained at a year IMPACT (Improving Mood-Promoting Access to Collaborative Treatment) Program
17 PRINCIPLES OF TREATMENT: MEDICATIONS Medication monotherapy is preferred in older adults to minimize side effects and drug interactions Start with half the dose, but usually requires titrating to full dosage to see response Treatment duration: 4-6 weeks to see response, may take 8-16 weeks Follow-up at 2 weeks to check drug tolerance Continuation of treatment to prevent relapse For 6-12 months past full remission Maintenance treatment to prevent recurrence Duration varies depending on severity Chronic therapy if 3+ episodes of depression
18 EFFICACY OF TREATMENT Only 50% of patients with major depressive fully respond to initial antidepressant therapy An additional 1/3 recover when Antidepressant is switched to another agent or Augmented with psychotherapy or Augmented with second agent For those who recover, 40-60% will experience a recurrence
19 FIRST WEEKS OF TREATMENT More depression, slower response 4 weeks is a good predictor of success of treatment at 12 weeks 1/3 non-responders 1/3 partial responders 1/3 full responders
20 PHARMACOLOGIC THERAPY SSRIs are first-line No more effective than TCAs but better tolerated SNRIs (venlafaxine, duloxetine) Useful if co-existing neuropathic pain Diastolic HTN Mirtazapine Good if insomnia, agitation/restlessness, anorexia/weight loss Give low dose at night, higher doses in the morning Buproprion Sustained release (Q12H) is preferred (3 different formulations) Seizure (rare, associated with IR formulation), diastolic HTN Activating, good for patients with lethargy, insomnia at high doses TCAs and MAO Inhibitors: 3 rd line, significant side-effects, used for resistant sx, best managed by psych
21 PHARMACOLOGICAL THERAPY Trazodone Soporific at low doses Anti-depressant at higher doses but also more anticholinergic SEs & sedation Atypical antipsychotics Adjunctive treatment for MDD that does not respond to monotherapy Not recommended as monotherapy to due increased side-effects Methylphenidate used as adjunctive therapy w/ SSRI, but increase risk of CV events
22 SSRIS Most drug interactions: fluoxetine, fluvoxamine, paroxetine Potent inhibitors of CYP P450 enzymes Fluoxetine Longest half-life; anorexia, nausea, agitation Paroxetine Most anticholinergic, shortest halflife (most likely to cause withdrawal syndrome) Side effects Serotonin syndrome Hyponatremia (SIADH) Sweating Sexual dysfunction Weight gain GI upset, diarrhea, anorexia CNS effects (insomnia or sedation may occur) Akathisia Enhanced physiologic tremor Long QT (citalopram 20mg) Hiemke C, et al. Pharmacology & Therapeutics. 2000;85:11-28.
23 SSRIS SSRI discontinuation syndrome Taper over 2-4 weeks to minimize withdrawal sx Exception: fluoxetine does not need to be tapered (long half-life) Drug-Induced Serotonin Syndrome Confusion, hyperactivity, delirium, muscle twitching, excessive sweating, diarrhea, fever risk: any combination of SSRI, SNRI, MAOI, TCA, trazodone, bupropion, mirtazapine, tramadol Linezolid (MAOI property)
24 PRINCIPLES OF TREATMENT: ECT ECT is an alternative for older adults who cannot tolerate medications Are not responding Have severe symptoms affecting function ECT is generally well-tolerated in older adults
25 ECT Highly effective treatment for MDD and mania May be first-line therapy for patients with High suicide risk Life-threatening symptoms (refusal to eat/drink) Severe sx affecting function Typically no lasting cognitive deficits Causes transient memory loss Typically 2-3 treatments/wk for 6-12 treatments Maintenance ECT for some patients
26 PRE-ECT RISK ASSESSMENT Low risk procedure per ACC-AHA guidelines If no major risk factors (recent MI, unstable angina, uncompensated HF, severe valvular disease, serious arrhythmia) then no testing Contraindications Intracranial masses/increased pressure Recent stroke (within 1 month) Evaluation: H&P, BMP, EKG Medical Evaluation of Patient Undergoing ECT NEJM 2009; 360:1437.
27 ECT COMPLICATIONS Hypertension (expected for min post ECT) Asystole or bradycardia Myocardial ischemia (rare) Headache Transient memory loss/delirium (retrograde or anterograde) More likely with advanced age 25-50% persist > 6 mo Falls Medical Evaluation of Patient Undergoing ECT NEJM 2009; 360:1437.
28 PSYCHOTIC DEPRESSION Study of Pharmacotherapy of Psychotic Depression (STOP-PD) STOP-PD found 60% remission in patients who took sertraline & olanzapine over 12 weeks Combination of antidepressant + antipsychotic agent can be effective initial strategy Electroconvulsive therapy (ECT) is also effective but typically not first-line Referral to a psychiatrist
Depression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationQuick Guide to Common Antidepressants-Adults
Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationDepression & Suicide 7/11/2017 DISCLOSURES. DSM 5 Depressive Disorders. Objectives
DISCLOSURES Depression & Suicide July 19, 2017 GenaLynne C. Mooneyham, MD, MS Pediatrics/Psychiatry/Child & Adolescent Psychiatry No financial disclosures There may be discussion of off label medication
More information9/24/2012. Amer M Burhan, MBChB, FRCP(C)
Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression
More informationRealities of Depression in Primary Care Setting
Realities of Depression in Primary Care Setting Jaroslava Salman, MD Department of Supportive Care Medicine Division of Psychiatry Click to edit Master Presentation Date August 4 th 2018 Disclosure I have
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationObjectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS
MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private
More informationDisclosure Information
Disclosure Information I have no financial relationships to disclose. I will discuss the off label use of several depression and anxiety medications in pediatric population Pediatric Depression & Anxiety
More informationAnxiety and Depression Management for General Providers
Anxiety and Depression Management for General Providers Meaghan Rudolph RN MS PMHCNS-BC Stephanie Mahnks RN MSN PMHNP-BC Massachusetts General Hospital Dept of Psychiatry Nothing to disclose Disclosures
More informationPsychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationSome newer, investigational approaches to treating refractory major depression are being used.
CREATED EXCLUSIVELY FOR FINANCIAL PROFESSIONALS Rx FOR SUCCESS Depression and Anxiety Disorders Mood and anxiety disorders are common, and the mortality risk is due primarily to suicide, cardiovascular
More informationConsultant Pharmacist Approach to Major Depressive Disorder
Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO Objectives What is Depression? Discuss the epidemiology of depression
More informationConsultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO
Consultant Pharmacist Approach to Major Depressive Disorder ALAN OBRINGER RPH, CPH, CGP PRESIDENT/OWNER GUARDIAN PHARMACY OF ORLANDO Objectives What is Depression? Discuss the epidemiology of depression
More informationAssessing and Treating Depression and Anxiety in Children with Cancer Anna (Nina) Muriel, MD, MPH
Assessing and Treating Depression and Anxiety in Children with Cancer Anna (Nina) Muriel, MD, MPH Chief, Division of Pediatric Psychosocial Oncology Department of Psychosocial Oncology and Palliative Care
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2010 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationVA/DOD CLINICAL PRACTICE GUIDELINE
VA/DOD CLIICAL PRACTICE GUIDELIE Management of Major Depressive Disorder (MDD) KE ELEMETS OF THE MDD GUIDELIE Screen annually for Depression (PHQ-2) Assess for Suicide Risk Obtain Standardized Symptom
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationPartners in Care Quick Reference Cards
Partners in Care Quick Reference Cards Supported by the Agency for Healthcare Research and Quality MR-1198/8-AHRQ R This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly
More informationGeriatric Depression Diagnosis and Treatment. Disclosures. Objectives 11/4/2018. None
Geriatric Depression Diagnosis and Treatment David Mansoor, MD Assistant Professor of Psychiatry OHSU/PVAMC March 2018 Disclosures None Objectives Introduction / Epidemiology Assessment Differential Diagnosis
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationPharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007
Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual
More informationNon-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450
James A. Bourgeois, O.D., M.D. Vice Chair Clinical Affairs and Director, CL Service University of California San Francisco Non-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450 Localize! Sequence! 1
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationDepression Workshop 26 January 2007
Depression Workshop 26 January 2007 Leslie G Walker Professor of Cancer Rehabilitation Donald M Sharp Senior Lecturer in Behavioural Oncology Mary B Walker Senior Clinical and Research Nurse Specialist
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationAntidepressant Pharmacology An Overview
Figure 1. Antidepressant Pharmacology An Overview Source: NEJM 2005;353:1819-34 Figure 2. 1 Figure 3: Antidepressant Pharmacology pictures: Weak inhibition Bupropion NOTE: CYP enzymes noted are those inhibited
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationDisclosures - None. Learning Objectives. Emerging Issues Prevalence of Mood Disorders. Update on Depression-2012
Disclosures - None Update on Depression-2012 Russell G. Vasile, M. D. Associate Professor of Psychiatry Beth Israel Deaconess Medical Center Harvard Medical School Learning Objectives Understand the spectrum
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationDepression Assessment and Management. John Kern MD Clinical Professor University of Washington
Depression Assessment and Management John Kern MD Clinical Professor University of Washington Handouts Antidepressant Treatment Flowchart Managing antidepressant nonresponse handouts 2 Diagnosis PHQ-9
More informationAffective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018
Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed
More informationPractice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association
Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association Our clinical advisor adds updated advice on electroconvulsive therapy, transcranial magnetic
More informationResident Rotation: Collaborative Care Consultation Psychiatry
Resident Rotation: Collaborative Care Consultation Psychiatry Anna Ratzliff, MD, PhD Ramanpreet Toor, MD James Basinski, MD With contributions from: Jürgen Unützer, MD, MPH, MA Jennifer Sexton, MD, Catherine
More information3/27/2013. Objectives. Psychopharmacology at the End of Life Nicole Thurston, MD
Psychopharmacology at the End of Life Nicole Thurston, MD Psychiatrist Mountain States Tumor Institute Objectives Describe 2 common psychiatric symptoms that can present at or near end of life. Review
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationAnti-Depressant Medications
Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change
More informationPSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust
PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions
More informationOptimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE
Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Chan-Hyung Kim, MD Severance Mental Health Hospital Institute of Behavioral Science in Medicine Diagnostic Criteria Pyramid Etiologic Pathophysiologic
More informationWhere to from Here? Evidence-Based Strategies for Treatment of Refractory Depression
Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.
More informationSUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816
SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816 SPA PCP Treatment & Referral Guideline Managing Depression in Older Adults Developed March 1, 2003 Revised September 21,
More informationDepression in the Eldery Handout Package
Depression in the Eldery Handout Package Depression in the Elderly 1 Learning Objectives Upon completion of this module, you should be able to: 1. State the prevalence and describe the consequences of
More informationDaniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School
Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School of Psychology, Fuller Theological Seminary Medical
More informationTREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD
TREATMENT OF DEPRESSION IN LATE LIFE Robert Kohn, MD WHY TREAT ELDERLY PERSONS Major depression is not a normal part of aging The rates are lower than younger cohorts The prevalence rates are still high
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationTreatment-resistant depression in primary care
Treatment-resistant depression in primary care Interprofessional CME, October 2017 Brian J. Mickey, MD, PhD Associate Professor School of Medicine Department of Psychiatry Disclosures Speakers bureau:
More informationFamily Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University
APPROACH TO DEPRESSION IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University DISCLOSURE Speaker/Presenter Disclosure
More informationA new Anatomy of Melancholy: rethinking depression and resilience
A new Anatomy of Melancholy: rethinking depression and resilience Prof Declan McLoughlin Dept of Psychiatry & Trinity College Institute of Neuroscience Trinity College Dublin St Patrick s University Hospital
More informationDEPRESSION An introduction to aging science brought to you by the American Federation for Aging Research
infoaging guides DISEASES OF AGING DEPRESSION An introduction to aging science brought to you by the American Federation for Aging Research WHAT IS DEPRESSION AND WHY IS IT IMPORTANT? Depression is a mood
More informationAntidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 5. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationOverview. Part II: Part I: Screening for Depression and Anxiety Risk Assessment Diagnosis of Depressive Disorders
1 Learning Objectives 1. Providers will become familiar with methods of screening for depression and anxiety. 2. Providers will become more comfortable with diagnosis and management of these common pediatric
More informationDepression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012
Depression in Older Adults Paul Boulware, MD Arizona Neurological Institute April 22, 2012 What is it? Major depressive disorder is a syndrome, a collection of symptoms Presentation is variable among individuals
More informationGuilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.
1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number
More informationAdvances in Diagnosis, Neurobiology, and Treatment of Mood Disorders
Advances in Diagnosis, Neurobiology, and Treatment of Mood Disorders June 13-14, 2016 Field House Coral Gables University of Miami Coral Gables, FL Management of Depression in the Geriatric Patient Samir
More informationDepression in adults: treatment and management
1 2 3 4 Depression in adults: treatment and management 5 6 7 8 Appendix V3: recommendations that have been deleted of changed from 2009 guideline Depression in adults: Appendix V3 1 of 22 1 Recommendations
More information8/15/14. Julie Wood, MD Southwestern Behavioral Healthcare & Mulberry Memory Clinic
Julie Wood, MD Southwestern Behavioral Healthcare & Mulberry Memory Clinic SILVER TSUNAMI DEPRESSION STATS DIAGNOSTIC CRITERIA ASSESSMENT OF GERIATRIC DEPRESSION RISK FACTORS TREATMENT OPTIONS FOR GERIATRIC
More informationDepression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:
Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More information1/3/2017 DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT
DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT Victoria Braund MD FACP CMD Division of Geriatrics NorthShore University HealthSystem Assistant Clinical Professor University of Chicago Pritzker
More informationDEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT
DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT Victoria Braund MD FACP CMD Division of Geriatrics NorthShore University HealthSystem Assistant Clinical Professor University of Chicago Pritzker
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2012 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationDepression in the Medically Ill
Mayo School of Continuous Professional Development Psychiatry in Medical Settings February 9 th, 2017 Depression in the Medically Ill David Katzelnick, M.D. Professor of Psychiatry, Mayo Clinic College
More information48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014
48 th Annual Meeting Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Published in 2013 Most published treatment guidelines
More informationDepression among Older Adults. Prevalence & Intervention Strategies
Depression among Older Adults Prevalence & Intervention Strategies Definition Depression is a complex syndrome complex characterized by mood disturbance plus variety of cognitive, psychological, and vegetative
More informationJoel V. Oberstar, M.D. 1
Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical
More informationTREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationLife is a miserable thing. I have decided to spend my life thinking about it. Irvin D. Yalom, The Schopenhauer Cure
Life is a miserable thing. I have decided to spend my life thinking about it. Irvin D. Yalom, The Schopenhauer Cure GERIATRIC DEPRESSION Samir Patel, MD Geriatrics and Palliative Medicine and Geriatric
More informationDepressive, Bipolar and Related Disorders
Depressive, Bipolar and Related Disorders Robert Kelly, MD Assistant Professor of Psychiatry Weill Cornell Medical College White Plains, New York Lecture available at www.robertkelly.us Financial Conflicts
More informationANXIETY DISORDERS IN THE ELDERLY IMPACT OF LATE-LIFE ANXIETY CHANGES IN DSM-5 THE COSTS 6/4/2015 LATE-LIFE ANXIETY TOPICS TO BE COVERED
LATE-LIFE ANXIETY TOPICS TO BE COVERED ANXIETY DISORDERS IN THE ELDERLY Dr. Lisa Talbert Classes of Anxiety Disorders Diagnosis Comorbidities Pharmacologic Management Psychological Management LATE LIFE
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More informationEffective Date: 5/28/2014 Version: 2.0 (Revised: 10/12/2015) Approval By: CCC Clinical Delivery Steering Planned Review Date: (04/47/2017)
Protocol Title: Depression & Generalized Anxiety Disorder Effective Date: 5/28/2014 Version: 2.0 (Revised: 10/12/2015) Approval By: CCC Clinical Delivery Steering Planned Review Date: (04/47/2017) Group
More informationDepression: Assessment and Treatment For Older Adults
Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca
More informationDepartment of Psychiatry & Behavioral Sciences. University of Texas Medical Branch
Depression in Childhood: Advances and Controversies in Treatment Karen Dineen Wagner, MD, PhD Marie B. Gale Centennial Professor & Vice Chair Department of Psychiatry & Behavioral Sciences Director, Division
More informationManagement Of Depression And Anxiety
Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate
More informationMental Illness Through Menopause
Mental Illness Through Menopause Susan Hatters Friedman, MD Associate Professor of Psychological Medicine University of Auckland Mental Illness: Depression Bipolar Schizophrenia PTSD & Anxiety Comorbidity
More informationMore Than Just Moody Blaise Aguirre, MD Child and Adolescent Psychiatrist McLean Hospital Assistant Professor of Psychiatry Harvard Medical School
More Than Just Moody Blaise Aguirre, MD Child and Adolescent Psychiatrist McLean Hospital Assistant Professor of Psychiatry Harvard Medical School Keep in Mind In the U.S., approximately 10-15% of children/adolescents
More informationHow to treat depression with medication: Some rules of thumb
How to treat depression with medication: Some rules of thumb R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon. Consultant Psychiatrist Regional
More informationPsychosocial Problems In Reproductive Health Of Elders
Psychosocial Problems In Reproductive Health Of Elders Dr. Sonia Oveisi Maternity and Child Health Assistant Professor of Qazvin University of Medical Science 6/2/2014 1 Goals 1. Definition 2. Epidemiology
More informationDisclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression
Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression Disclosures The speakers have no disclosures. Lisa Ochoa-Frongia, MD Christina Mangurian, MD, MAS L. Elizabeth
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationReviews/Evaluations. Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients. Pharmacotherapeutic Options
Reviews/Evaluations Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients Childhood major depressive disorder (MDD) has become recognized as a serious and common illness affecting between
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More information